Protein tyrosine phosphatase controls breast cancer invasion through the expression of matrix metalloproteinase-9

BMB Reports

Volumn 46, Issue 11, 2013, Pages 533-538

  Hwang, Bo Mi ^a   Chae, Hee Suk ^a   Jeong, Young Ju ^a   Lee, Young Rae ^b   Noh, Eun Mi ^a   Youn, Hyun Zo ^a   Jung, Sung Hoo ^a   Yu, Hong Nu ^c   Chung, Eun Yong ^a,d   Kim, Jong Suk ^a  

^a Chonbuk National University Medical School   (South Korea)

^b Wonkwang University   (South Korea)

^c DALIAN UNIVERSITY   (China)

^d The Catholic University of Korea   (South Korea)

Author keywords

Mcf 7; Metastasis; Mmp; Nf b; Ptp

Indexed keywords

4 HYDROXY 3,3 DIMETHYL 2H BENZO(G)INDOLE 2,5(3H) DIONE; 4-HYDROXY-3,3-DIMETHYL-2H-BENZO(G)INDOLE-2,5(3H)-DIONE; CARCINOGEN; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDOLE DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN TYROSINE PHOSPHATASE; TRANSCRIPTION FACTOR AP 1;

ARTICLE; BREAST TUMOR; CELL MOTION; CELL SURVIVAL; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MCF 7 CELL LINE; METABOLISM; PATHOLOGY;

BREAST NEOPLASMS; CARCINOGENS; CELL MOVEMENT; CELL SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INDOLES; MATRIX METALLOPROTEINASE 9; MCF-7 CELLS; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; PROTEIN TYROSINE PHOSPHATASES; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION FACTOR AP-1;

EID: 84890204884     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2013.46.11.053     Document Type: Article

References (34)

1. Osborne, C. K., Hobbs, K. and Clark, G. M. (1985) Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice. Cancer Res. 45, 584-590.
2. Kohrmann, A., Kammerer, U., Kapp, M., Dietl, J. and Anacker, J. (2009) Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: New findings and review of the literature. BMC Cancer 9, 188.
3. Page-McCaw, A., Ewald, A. J. and Werb, Z. (2007) Matrix metalloproteinases and the regulation of tissue remodelling. Nat. Rev. Mol. Cell Biol. 8, 221-233.
4. McGowan, P. M. and Duffy, M. J. (2008) Matrix metalloproteinase expression and outcome in patients with breast cancer: analysis of a published database. Ann. Oncol. 19, 1566-1572.
5. Price, J. E., Polyzos, A., Zhang, R. D. and Daniels, L. M. (1990) Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res. 50, 717-721.
6. Himelstein, B. P., Canete-Soler, R., Bernhard, E. J., Dilks, D. W. and Muschel, R. J. (1994) Metalloproteinases in tumor progression: the contribution of MMP-9. Invasion Metastasis 14, 246-258.
7. Zucker, S., Cao, J. and Chen, W. T. (2000) Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment. Oncogene 19, 6642-6650.
8. Genersch, E., Hayess, K., Neuenfeld, Y. and Haller, H. (2000) Sustained ERK phosphorylation is necessary but not sufficient for MMP-9 regulation in endothelial cells: involvement of Ras-dependent and -independent pathways. J. Cell Sci. 113 (Pt 23), 4319-4330.
9. Jallal, B., Mossie, K., Vasiloudis, G., Knyazev, P., Zachwieja, J., Clairvoyant, F., Schilling, J. and Ullrich, A. (1997) The receptor-like protein-tyrosine phosphatase DEP-1 is constitutively associated with a 64-kDa protein serine/threonine kinase. J. Biol. Chem. 272, 12158-12163.
10. Wang, F. M., Liu, H. Q., Liu, S. R., Tang, S. P., Yang, L. and Feng, G. S. (2005) SHP-2 promoting migration and metastasis of MCF-7 with loss of E-cadherin, dephosphorylation of FAK and secretion of MMP-9 induced by IL-1beta in vivo and in vitro. Breast Cancer Res. Treat. 89, 5-14.
11. Han, S. S., Keum, Y. S., Seo, H. J. and Surh, Y. J. (2002) Curcumin suppresses activation of NF-kappaB and AP-1 induced by phorbol ester in cultured human promyelocytic leukemia cells. J. Biochem. Mol. Biol. 35, 337-342.
12. Chambers, A. F. and Matrisian, L. M. (1997) Changing views of the role of matrix metalloproteinases in metastasis. J. Natl. Cancer Inst. 89, 1260-1270.
13. Stetler-Stevenson, W. G., Hewitt, R. and Corcoran, M. (1996) Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic. Semin. Cancer Biol. 7, 147-154.
14. Deryugina, E. I. and Quigley, J. P. (2006) Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev. 25, 9-34.
15. Soulsby, M. and Bennett, A. M. (2009) Physiological signaling specificity by protein tyrosine phosphatases. Physiology (Bethesda) 24, 281-289.
16. Zhang, Z. Y. (2005) Functional studies of protein tyrosine phosphatases with chemical approaches. Biochim. Biophys. Acta. 1754, 100-107.
17. Freiss, G. and Vignon, F. (2004) Protein tyrosine phosphatases and breast cancer. Crit. Rev. Oncol. Hematol. 52, 9-17.
18. Wiener, J. R., Kerns, B. J., Harvey, E. L., Conaway, M. R., Iglehart, J. D., Berchuck, A. and Bast, R. C. Jr. (1994) Overexpression of the protein tyrosine phosphatase PTP1B in human breast cancer: association with p185c-erbB-2 protein expression. J. Natl. Cancer Inst. 86, 372-378.
19. Aceto, N., Sausgruber, N., Brinkhaus, H., Gaidatzis, D., Martiny-Baron, G., Mazzarol, G., Confalonieri, S., Quarto, M., Hu, G., Balwierz, P. J., Pachkov, M., Elledge, S. J., van Nimwegen, E., Stadler, M. B. and Bentires-Alj, M. (2012) Tyrosine phosphatase SHP2 promotes breast cancer progression and maintains tumor-initiating cells via activation of key transcription factors and a positive feedback signaling loop. Nat. Med. 18, 529-537.
20. Pellikainen, J. M., Ropponen, K. M., Kataja, V. V., Kellokoski, J. K., Eskelinen, M. J. and Kosma, V. M. (2004) Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis. Clin. Cancer Res. 10, 7621-7628.
21. Scorilas, A., Karameris, A., Arnogiannaki, N., Ardavanis, A., Bassilopoulos, P., Trangas, T. and Talieri, M. (2001) Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patients. Br. J. Cancer 84, 1488-1496.
22. Cho, H. J., Kang, J. H., Kwak, J. Y., Lee, T. S., Lee, I. S., Park, N. G., Nakajima, H., Magae, J. and Chang, Y. C. (2007) Ascofuranone suppresses PMA-mediated matrix metalloproteinase-9 gene activation through the Ras/Raf/ MEK/ERK- and Ap1-dependent mechanisms. Carcinogenesis. 28, 1104-1110.
23. Kajanne, R., Miettinen, P., Mehlem, A., Leivonen, S. K., Birrer, M., Foschi, M., Kahari, V. M. and Leppa, S. (2007) EGF-R regulates MMP function in fibroblasts through MAPK and AP-1 pathways. J. Cell Physiol. 212, 489-497.
24. Srivastava, A. K., Qin, X., Wedhas, N., Arnush, M., Linkhart, T. A., Chadwick, R. B. and Kumar, A. (2007) Tumor necrosis factor-alpha augments matrix metalloproteinase-9 production in skeletal muscle cells through the activation of transforming growth factor-beta-activated kinase 1 (TAK1)-dependent signaling pathway. J. Biol. Chem. 282, 35113-35124.
25. Newton, A. C. (1995) Protein kinase C: structure, function, and regulation. J. Biol. Chem. 270, 28495-28498.
26. Datta, R., Yoshinaga, K., Kaneki, M., Pandey, P. and Kufe, D. (2000) Phorbol ester-induced generation of reactive oxygen species is protein kinase cbeta -dependent and required for SAPK activation. J. Biol. Chem. 275, 41000-41003.
27. Schlingemann, J., Hess, J., Wrobel, G., Breitenbach, U., Gebhardt, C., Steinlein, P., Kramer, H., Furstenberger, G., Hahn, M., Angel, P. and Lichter, P. (2003) Profile of gene expression induced by the tumour promotor TPA in murine epithelial cells. Int. J. Cancer 104, 699-708.
28. Jemal, A., Murray, T., Ward, E., Samuels, A., Tiwari, R. C., Ghafoor, A., Feuer, E. J. and Thun, M. J. (2005) Cancer statistics, 2005. CA. Cancer J. Clin. 55, 10-30.
29. Chung, T. W., Moon, S. K., Chang, Y. C., Ko, J. H., Lee, Y. C., Cho, G., Kim, S. H., Kim, J. G. and Kim, C. H. (2004) Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: complete regression of hepatoma growth and metastasis by dual mechanism. FASEB J. 18, 1670-1681.
30. Eberhardt, W., Huwiler, A., Beck, K. F., Walpen, S. and Pfeilschifter, J. (2000) Amplification of IL-1 beta-induced matrix metalloproteinase-9 expression by superoxide in rat glomerular mesangial cells is mediated by increased activities of NF-kappa B and activating protein-1 and involves activation of the mitogen-activated protein kinase pathways. J. Immunol. 165, 5788-5797.
31. Fridman, R., Toth, M., Pena, D. and Mobashery, S. (1995) Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2), Cancer Res. 55, 2548-2555.
32. Yamamoto, Y. and Gaynor, R. B. (2001) Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. J. Clin. Invest. 107, 135-142.
33. Thanos, D. and Maniatis, T. (1995) NF-kappa B: a lesson in family values. Cell. 80, 529-532
34. Noh, E. M., Youn, H. J., Jung, S. H., Han, J. H., Jeong, Y. J., Chung, E. Y., Jung, J. Y., Kim, B. S., Lee, S. H., Lee, Y. R. and Kim, J. S. (2010) Cordycepin inhibits TPA-induced matrix metalloproteinase-9 expression by suppressing the MAPK/AP-1 pathway in MCF-7 human breast cancer cells. IJMM 25, 255-260